134 related articles for article (PubMed ID: 38865319)
1. Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care.
Ononge S; Nakimuli A; Byamugisha J; Adroma M; Kiondo P; Easterling T; Bracken H
PLoS One; 2024; 19(6):e0286361. PubMed ID: 38865319
[TBL] [Abstract][Full Text] [Related]
2. A novel 12-hour versus 24-hour magnesium sulfate regimen in the management of eclampsia and preeclampsia in Ghana (MOPEP Study): A randomized controlled trial.
Beyuo TK; Lawrence ER; Kobernik EK; Oppong SA
Int J Gynaecol Obstet; 2022 Nov; 159(2):495-504. PubMed ID: 35304745
[TBL] [Abstract][Full Text] [Related]
3. Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate.
Mundle S; Regi A; Easterling T; Biswas B; Bracken H; Khedekar V; Ratna Shekhavat D; Durocher J; Winikoff B
Pregnancy Hypertens; 2012 Jan; 2(1):32-8. PubMed ID: 26104987
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion.
Easterling T; Hebert M; Bracken H; Darwish E; Ramadan MC; Shaarawy S; Charles D; Abdel-Aziz T; Nasr AS; Safwal SM; Winikoff B
BMC Pregnancy Childbirth; 2018 Jul; 18(1):290. PubMed ID: 29976161
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of intramuscular loading dose of MgSO4 in severe pre-eclampsia/ eclampsia at a tertiary referral centre in Northwest Nigeria.
Okusanya BO; Garba KD; Ibrahim HM
Niger Postgrad Med J; 2012 Jun; 19(2):77-82. PubMed ID: 22728971
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a low-cost, low-power syringe pump to deliver magnesium sulfate intravenously to pre-eclamptic women in a Malawian referral hospital.
Skerrett E; Kommwa E; Maynard K; Juarez A; Mataya R; Richards-Kortum R; Oden ZM
BMC Pregnancy Childbirth; 2017 Jun; 17(1):191. PubMed ID: 28629437
[TBL] [Abstract][Full Text] [Related]
8. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial.
Pascoal ACF; Katz L; Pinto MH; Santos CA; Braga LCO; Maia SB; Amorim MMR
Medicine (Baltimore); 2019 Aug; 98(32):e16779. PubMed ID: 31393402
[TBL] [Abstract][Full Text] [Related]
9. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.
Diaz V; Long Q; Oladapo OT
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD007388. PubMed ID: 37815037
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of low dose intramuscular magnesium sulphate (MgSO4) compared to intravenous regimen for treatment of eclampsia.
Saha PK; Kaur J; Goel P; Kataria S; Tandon R; Saha L
J Obstet Gynaecol Res; 2017 Oct; 43(10):1543-1549. PubMed ID: 28714170
[TBL] [Abstract][Full Text] [Related]
11. The WHO Safe Childbirth Checklist implementation: impact on the prescription of magnesium sulphate through a one-year longitudinal study.
da Silva Gama ZA; Medeiros WR; Saturno-Hernández PJ; de Meneses Sousa K; Mello MS; de Lima Vale É; de Souza Rosendo TMS; da Silva EMM; de Freitas MR
BMC Pregnancy Childbirth; 2020 Mar; 20(1):154. PubMed ID: 32164643
[TBL] [Abstract][Full Text] [Related]
12. PP164. Magnesium sulphate for prevention and treatment of eclampsia in low and middle income countries: Systematic review of tested regimens.
Gordon RM; Payne B; Firoz T; Magee L; Sawchuck D; Tu D; Vidler M; von Dadelszen P;
Pregnancy Hypertens; 2012 Jul; 2(3):328. PubMed ID: 26105485
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of loading dose alone versus pritchard regimen of magnesium sulphate, for seizure prophylaxis in severe preeclampsia.
Obanimoh AA; Isah AY; Abdullahi HI; Adewole ND; Ekele BA
Ann Afr Med; 2023; 22(2):153-159. PubMed ID: 37026195
[TBL] [Abstract][Full Text] [Related]
14. Loading Dose only versus Standard Dose Magnesium Sulfate Seizure Prophylaxis in Severe Pre-eclamptic Women.
Rimal SP; Rijal P; Bhatt R; Thapa K
JNMA J Nepal Med Assoc; 2017; 56(208):388-94. PubMed ID: 29453467
[TBL] [Abstract][Full Text] [Related]
15. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.
Lu JF; Nightingale CH
Clin Pharmacokinet; 2000 Apr; 38(4):305-14. PubMed ID: 10803454
[TBL] [Abstract][Full Text] [Related]
16. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial.
Ehrenberg HM; Mercer BM
Obstet Gynecol; 2006 Oct; 108(4):833-8. PubMed ID: 17012443
[TBL] [Abstract][Full Text] [Related]
17. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
[TBL] [Abstract][Full Text] [Related]
18. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
Ridge AL; Bero LA; Hill SR
BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
[TBL] [Abstract][Full Text] [Related]
19. Intravenous magnesium sulfate in the management of severe pre-eclampsia: A randomized study of 12-hour versus 24-hour maintenance dose.
Unwaha EA; Bello FA; Bello OO; Oladokun A
Int J Gynaecol Obstet; 2020 Apr; 149(1):37-42. PubMed ID: 31833059
[TBL] [Abstract][Full Text] [Related]
20. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.
Sibai BM; Lipshitz J; Anderson GD; Dilts PV
Obstet Gynecol; 1981 Feb; 57(2):199-202. PubMed ID: 7465124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
